Approval · Notice of Compliance 4917 · 2004
RENAGEL: Notice of Compliance 4917
Issued August 24, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4917
- Date
- August 24, 2004
- Company
- Genzyme Canada Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Phosphate binder
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RENAGEL | Not yet assigned | — |
Medicinal ingredients
- SEVELAMER HYDROCHLORIDE 403 MG per CAP
- SEVELAMER HYDROCHLORIDE 400 MG per TAB
- SEVELAMER HYDROCHLORIDE 800 MG per TAB